Improving Maternal and Neonatal Care-seeking Through a Video-informed Training Session During the Third Trimester of Pregnancy (Taabo T3)
14 september 2026 bijgewerkt door: Swiss Tropical & Public Health Institute
Improving Maternal and Neonatal Care-Seeking Through a Video-Informed Training Session During the Third Trimester of Pregnancy
This study is a randomized controlled trial evaluating the impact of a video-informed training session on maternal and newborn health care seeking in rural Côte d'Ivoire.
Studie Overzicht
Toestand
Nog niet aan het werven
Interventie / Behandeling
Gedetailleerde beschrijving
In Taabo, Côte d'Ivoire, many women do not receive recommended care during the third trimester of pregnancy or the early postpartum period, contributing to adverse maternal and neonatal health outcomes.
In this individual-level open-label randomized controlled trial, we will evaluate the impact of an information and planning intervention on timely care-seeking during the third trimester of pregnancy and the early postpartum period.
The study will enroll 800 women who are currently in the third trimester of pregnancy and randomize them to one of two groups: (1) control, or (2) information video and planning session for the pregnant women and her partner.
A baseline survey will be performed at the time of enrollment, and outcomes will be evaluated using an endline survey 6-8 weeks after the end of pregnancy.
The main outcome of the study is the number of health care contacts that women have between enrollment in the study and 6 weeks postpartum.
Studietype
Ingrijpend
Inschrijving (Geschat)
800
Fase
- Niet toepasbaar
Contacten en locaties
In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.
Studie Locaties
-
-
-
Taabo, Ivoorkust
- Centre Suisse de Recherches Scientifiques en Cote d'Ivoire
-
Contact:
- Siaka Koné, PhD
- Telefoonnummer: +2250749069627
- E-mail: Siaka.kone@csrs.ci
-
-
Deelname Criteria
Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Kind
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Nee
Beschrijving
Inclusion Criteria for Pregnant Women:
- Currently pregnant
- Aged 15 years or older
- Live in the area served by the Taabo Health & Demographic Surveillance System
- Estimated gestational age between 6 completed months of pregnancy and 8 completed months of pregnancy
Inclusion Criteria for Male Partners:
- Aged 15 or older
- Married to or currently the main romantic partner of a woman who is enrolled in the study
Studie plan
Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Onderzoek naar gezondheidsdiensten
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Geen tussenkomst: Control group
This group will not receive any intervention.
|
|
|
Experimenteel: Information Video and Planning Session group
This group will receive the study intervention, including an information video and planning session for the pregnant woman and her partner.
|
The study intervention is a video-informed information and planning session for health care during the third trimester, childbirth, and the first six weeks postpartum.
In this intervention, a member of the study team will show information videos to pregnant women and her partner, summarizing key recommendations for health and health care seeking during the third trimester of pregnancy and the first six weeks following childbirth.
After showing the videos, the study team member will guide the pregnant woman and her partner in a short discussion about planning for care-seeking during the third trimester and early postpartum period.
This discussion will include quizzing on the content of the information videos and discussions of care-seeking plans together with the couple.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Number of health care contacts as reported by women during endline survey
Tijdsspanne: From enrollment to 6 weeks postpartum (measured 6-8 weeks after the end of pregnancy)
|
Number of health care contacts that women have between enrollment in the study and 6 weeks postpartum, including antenatal care visits, childbirth, and postpartum care visits
|
From enrollment to 6 weeks postpartum (measured 6-8 weeks after the end of pregnancy)
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Number of antenatal care visits as reported by women during endline survey
Tijdsspanne: Between enrollment and the end of pregnancy (measured 6-8 weeks after the end of pregnancy)
|
Number of antenatal care visits
|
Between enrollment and the end of pregnancy (measured 6-8 weeks after the end of pregnancy)
|
|
Facility-based childbirth as reported by women during endline survey
Tijdsspanne: Measured 6-8 weeks after the end of pregnancy
|
Proportion of women who gave birth in a health facility
|
Measured 6-8 weeks after the end of pregnancy
|
|
Number of postpartum visits as reported by women during endline survey
Tijdsspanne: From the end of pregnancy to 6 weeks postpartum (measured 6-8 weeks after the end of pregnancy)
|
Number of postpartum care visits between the end of pregnancy and 6 weeks postpartum
|
From the end of pregnancy to 6 weeks postpartum (measured 6-8 weeks after the end of pregnancy)
|
|
Fetal movement counting as reported by women during endline surveys
Tijdsspanne: Measured 6-8 weeks after the end of pregnancy
|
The proportion of pregnant women who report counting fetal movements at least once during the final month of their pregnancy
|
Measured 6-8 weeks after the end of pregnancy
|
|
Perinatal mortality as reported by women during endline surveys
Tijdsspanne: Measured 6-8 weeks after end of pregnancy
|
The proportion of women who experience a stillbirth or neonatal death in the first seven days of life (perinatal mortality)
|
Measured 6-8 weeks after end of pregnancy
|
|
Neonatal mortality as reported by women during endline surveys
Tijdsspanne: Measured 6-8 weeks after end of pregnancy
|
The proportion of women whose child dies in the first 28 days of life
|
Measured 6-8 weeks after end of pregnancy
|
|
Average care-seeking knowledge scores among pregnant women and their partners
Tijdsspanne: Measured 6-8 weeks after the end of pregnancy
|
Average scores (among pregnant women and their partners) on assessments of knowledge of care-seeking recommendations during the third trimester and the early postpartum period, as measured using five questions during endline surveys with pregnant women and their partners. We create a Care-Seeking Knowledge Scale as follows: Participants receive 1 point if they respond with 3 or more when asked how many postpartum visits women should have during the first 6 weeks after childbirth; 1 point if they correctly name at least 3 danger signs for women during pregnancy; 1 point if they correctly name at least 3 danger signs for women during the first six weeks after childbirth; and 1 point if they correctly name at least 3 danger signs for newborns. Scores range from 0 to 4 with higher scores representing greater knowledge. |
Measured 6-8 weeks after the end of pregnancy
|
Medewerkers en onderzoekers
Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.
Studie record data
Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.
Bestudeer belangrijke data
Studie start (Geschat)
1 september 2026
Primaire voltooiing (Geschat)
1 mei 2027
Studie voltooiing (Geschat)
1 mei 2027
Studieregistratiedata
Eerst ingediend
8 september 2026
Eerst ingediend dat voldeed aan de QC-criteria
8 september 2026
Eerst geplaatst (Werkelijk)
14 september 2026
Updates van studierecords
Laatste update geplaatst (Werkelijk)
17 september 2026
Laatste update ingediend die voldeed aan QC-criteria
14 september 2026
Laatst geverifieerd
1 september 2026
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 2026-19
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
JA
Beschrijving IPD-plan
De-identified data files and analytic code will be posted on public repositories at the time of publication of results.
IPD-tijdsbestek voor delen
We plan to share IPD and supporting information at the time of publication.
IPD-toegangscriteria voor delen
IPD and supporting information will be made available on public repositories.
IPD delen Ondersteunend informatietype
- LEERPROTOCOOL
- SAP
- ICF
- ANALYTIC_CODE
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Nee
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Nee
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .